Centene Announces New Executive Leadership Structure
Rhea-AI Summary
Centene (NYSE: CNC) announced two senior leadership moves on April 6, 2026: Daniel Finke is hired as Group President, Markets and Commercial and Michael Carson is appointed Group President, Medicare and Specialty, both reporting to CEO Sarah London.
Finke will oversee Medicaid and Commercial segments and joins from Convey Health Solutions with prior roles at CVS/Aetna. Carson expands oversight of Medicare Advantage, Part D, Duals, and Specialty after joining Centene in January 2024 as Wellcare CEO.
AI-generated analysis. Not financial advice.
Positive
- Daniel Finke hired as Group President, Markets and Commercial
- Michael Carson promoted to Group President, Medicare and Specialty
- Finke brings 20+ years of health plan leadership and CVS/Aetna experience
- Carson expands oversight to Medicare Advantage, Part D, Duals, and Specialty
Negative
- None.
News Market Reaction – CNC
On the day this news was published, CNC gained 0.83%, reflecting a mild positive market reaction. Argus tracked a peak move of +3.0% during that session. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $143M to the company's valuation, bringing the market cap to $17.41B at that time.
Data tracked by StockTitan Argus on the day of publication.
Appoints Daniel Finke to Group President, Markets and Commercial and Wellcare CEO Michael Carson to Group President, Medicare and Specialty
"We are pleased to recognize Michael's continued leadership and excited to leverage Dan's deep industry expertise and track record of strategic execution," said Sarah London, Chief Executive Officer of Centene. "Their collective experience will be instrumental as we continue to strengthen performance across the portfolio and deliver sustainable, profitable growth."
Finke, a seasoned healthcare executive with more than two decades of experience leading and scaling complex health plan organizations across government and commercial markets, will oversee the Medicaid and Commercial segments. He joins Centene from Convey Health Solutions, where he served as Chief Executive Officer. Prior to joining Convey, he was Executive Vice President of CVS Health and President of Aetna, leading strategy and operations spanning Medicare, Medicaid, and Commercial insurance businesses.
"I am excited to join Centene at a time of meaningful opportunity across government-sponsored healthcare and the individual market," said Finke. "Centene's mission-driven focus and strong market presence position the company to deliver innovative, high-quality solutions for members, providers and government partners. I look forward to working with the leadership team to drive long-term value for our stakeholders, including by positively impacting the health of the communities we serve."
As Group President, Medicare and Specialty, Michael Carson will have expanded oversight of Centene's Medicare Advantage, Medicare Part D, Duals, and Specialty businesses. Carson's experience spans nearly three decades of healthcare leadership. Prior to joining Centene in January 2024 as CEO of its Medicare business, Wellcare, Carson served as Chief Executive Officer for Bright Healthcare and Harvard Pilgrim Health Care, as well as CareAbout, a multi-specialty, value-based care delivery organization.
"In this expanded role, I will continue to build on the strong foundation we have established across our Medicare and specialty businesses," said Group President, Medicare and Specialty, Michael Carson. "As the healthcare landscape evolves, our focus remains on improving affordability, access, and outcomes for the members we serve. In particular, we look forward to deepening our ability to provide a better, more integrated experience to those who need it most, including those who are dually eligible for Medicaid and Medicare."
About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://investors.centene.com/.
Forward-Looking Statements
All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "predict," "intend," "seek," "target," "goal," "potential," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our expected future operating or financial performance, changes in laws and regulations, market opportunity, quality, member experience, expectations concerning pricing actions, competition and our investments. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, performance or achievements to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. All forward-looking statements included in this press release are based on information available to us on the date hereof. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events, or otherwise, after the date hereof. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to design and price products that are competitive and/or actuarially sound; our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical costs; rate cuts, insufficient rate changes or other payment reductions or delays by government payors affecting our government businesses; the effect of social, economic, and political conditions, geopolitical events and state and federal policies, including the amount and terms of state and federal funding for government-sponsored healthcare programs, including as a result of changes in
View original content to download multimedia:https://www.prnewswire.com/news-releases/centene-announces-new-executive-leadership-structure-302734400.html
SOURCE Centene Corporation